Cerenome Announces In-Network Provider Agreement With Health Care Service Corporation For CNSide CSF Assay, Effective August 1; Total Contracted Coverage Reaches About 153 Million
Share
Why It Matters
Cerenome made a deal so more health insurance customers can use their new brain fluid test starting in August. This shows the company is growing its business and more people might be able to afford their product.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.